Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
RMD Open|May 7, 2020
Impending radiographic erosive progression over the following year in a cohort of consecutive patients with inflammatory polyarthritis: prediction by serum biomarkersNathalie Carrier, Artur J de Brum-Fernandes, Patrick Liang, et al.
Arthritis Research & Therapy|February 3, 2016
Serum levels of 14-3-3η protein supplement C-reactive protein and rheumatoid arthritis-associated antibodies to predict clinical and radiographic outcomes in a prospective cohort of patients with recent-onset inflammatory polyarthritisNathalie Carrier, Anthony Marotta, Artur J de Brum-Fernandes, et al.
Rheumatology (Oxford, England)|July 26, 2015
Depressive symptoms predict future simple disease activity index scores and simple disease activity index remission in a prospective cohort of patients with early inflammatory polyarthritisCharlotte Leblanc-Trudeau, Patricia L Dobkin, Nathalie Carrier, et al.
Arthritis Research & Therapy|May 19, 2005
Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritisGilles Boire, Pierre Cossette, Artur J de Brum-Fernandes, et al.
Open Access Rheumatology : Research and Reviews|May 16, 2017
Variations in the clinical practice of physicians managing Takayasu arteritis: a nationwide surveyLillian Barra, Patrick Liang, Susanne M Benseler, et al.
Arthritis Research & Therapy|April 29, 2014
Serum C-X-C motif chemokine 13 is elevated in early and established rheumatoid arthritis and correlates with rheumatoid factor levelsJonathan D Jones, B JoNell Hamilton, Gregory J Challener, et al.
The Open Rheumatology Journal|April 21, 2015
Development of Canadian Recommendations for the Management of ANCA-Associated Vasculitides: Results of the National Needs Assessment QuestionnaireLeilani Famorca, Marinka Twilt, Lillian Barra, et al.
Canadian Journal of Kidney Health and Disease|November 12, 2015
CanVasc recommendations for the management of antineutrophil cytoplasm antibody (ANCA)-associated vasculitides - Executive summaryLucy McGeoch, Marinka Twilt, Leilani Famorca, et al.
The Journal of Rheumatology|November 3, 2015
CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated VasculitidesLucy McGeoch, Marinka Twilt, Leilani Famorca, et al.
Rheumatology (Oxford, England)|February 22, 2023
CanVasc consensus recommendations for the use of avacopan in antineutrophil cytoplasm antibody-associated vasculitis: 2022 addendumDavid Turgeon, Volodko Bakowsky, Corisande Baldwin, et al.
Pageof 3